A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus

Phase 1 Completed 35 enrolled AstraZeneca

RandomizedSequentialQuadruple-blindTreatment

Summary

This Phase I study will gather important information on the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5004 in both healthy Japanese participants and Japanese participants with T2DM.

Timeline

Start: 2024-11-02
Primary completion: 2025-03-13
Completion: 2025-03-13

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AZD5004	Unknown	—	Oral

A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications